Added to YB: 2023-10-09
Pitch date: 2023-10-09
RYZB:US [bullish]
RayzeBio, Inc.
+197.15%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
RayzeBio, Inc. develops radiopharmaceutical therapeutics for the treatment of cancer. The company was incorporated in 2020 and is based in San Diego, California.
Market Cap
$3.7B
Pitch Price
$21.03
Price Target
N/A
Dividend
N/A
EV/EBITDA
-45.36
P/E
-7.13
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
RayzeBio, Inc. RYZB:US
A summary for this pitch has not been created yet.
Read full article (0 min)